According to a report by Grand View Research,
Inc., global hemostasis
and tissue sealing market is projected to value USD 7.4 billion
by 2022. Rising need for advanced products offering quick recovery from
post-surgical wounds and injuries is anticipated to propel product demand in
the forthcoming years. Such products are likely to cease bleeding caused by
surgical procedures and injuries. In addition, they are expected to prevent
occurrence of blood transfusions, hypovolemic shock, thrombocytopenia, and
post-operative complications.
Rise in surgeries owing to increasing number of
geriatric population can augment market growth. Rising cases of chronic
diseases leading to surgical procedures are anticipated to propel growth of
market in the coming years. Increasing use of hemostasis devices and sealants
to cease bleeding and hemorrhage over conventional products can fuel market
growth. Growing adoption of hemostatic solutions for minimally invasive
surgeries for urology can augment growth of market during the forecast period
(2012 to 2022).
Lack of reimbursement policies for hemostats
and issue sealing agents can hinder growth of market to some extent. In
addition, increasing cost of surgical procedures and required surgical
equipment can further restrict market growth during the forecast period.
Access Research Report
of Hemostasis And Tissue Sealing Agents Market@: www.grandviewresearch.com/industry-analysis/hemostasis-tissue-sealing-agents-market
The hemostasis and tissue sealing market can be
segregated on the basis of product and region. Based on product, the market can
be bifurcated into topical hemostats and adhesives & tissue sealants.
Topical hemostats can be segmented further into active, mechanical, and
flow-able hemostats. They can be used along with traditional treatment to offer
quick, cost-efficient, and easy absorbability of hemostat agent,
non-antigenicity, and minimal tissue reactivity. Hemostasis plays a major role
in fibrinolysis, coagulation, and platelet aggregation pathways through
activation of these factors. Hemostats can consist of hemostatic agents and
method of delivery involves devices such as prefilled syringes or ready-to-use
applicators.
On the contrary, adhesives and sealants are
expected to play significant role in managing blood loss during surgeries. They
can bind and seal the damaged tissues. Binding can create a barrier over the
surgical wound and injured part and boost coagulation. Minimal invasion, less
post-surgical infections, prevention of discharge of other body fluids, and
faster procedure rate are factors expected to propel demand for adhesives and
sealants over sutures. They can be segmented further into natural, synthetic,
and adhesion barrier products based on sealants.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Regional segmentation includes Europe, North
America, Asia Pacific, Latin America, and Middle East & Africa. In 2014,
North America dominated the market and accounted for largest market share owing
to high prevalence of diabetes, cardiovascular diseases, and cancer within this
region. It can be accountable for over 30% market share by 2022. Increasing use
of adhesives and sealants in surgeries and other medical applications to
minimize post-surgery complications and expedite healing process can fuel
market growth in the region during the forecast period.
Europe followed North America in terms of
market share during 2014. It is expected to grow at CAGR of 8% during the
forecast period. Launch of innovative and advanced hemostat products such as
TISEEL, FLOSEAL, and HEMOPATCH can influence market growth in the region. In
addition, increasing number of surgeries owing to expanding geriatric
population base can bolster market growth
in this region.
In Asia Pacific, the market is anticipated to
witness significant growth during the forecast period owing to increased
surgical procedures and medical tourism. It is likely to gain market share of
25% by 2022 owing to cost effective environment and supportive policies. India,
Japan, and China are expected to be major revenue generators in this region
owing to availability of advanced treatments, developed healthcare
infrastructure, and a large patient pool. In addition, Singapore, Malaysia, and
other Asian countries are likely to expand in the coming years owing to
improvement in healthcare services and booming medical tourism.
Some of the leading companies offering
hemostasis and tissue sealing products are Pfizer Inc.; B. Braun Medical Inc.;
CryoLife, Inc.; C. R. Bard, Inc. , and
Advanced Medical Solutions Group plc. Most companies are expected to adopt
strategies such as incorporation of bacteriostatic properties and R&D in
the field of formulation development to maintain their market presence. In addition,
companies can also indulge in mergers and acquisitions to ensure sustainability
and regional expansion.
Access Press Release of
Hemostasis And Tissue Sealing Agents Market@: www.grandviewresearch.com/press-release/global-hemostasis-tissue-sealing-agents-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment